Shanghai Haixin Group Co., Ltd.'s (SHSE:600851) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 13% Last Week

Simply Wall StDec 12 22:06 ET

Shanghai Haixin Group (600851.SH): The operation scope of Shanghai Haixin Biotechnology Co., Ltd. does not involve AI medicine.

Gelonghui November 22nd | Shanghai haixin group (600851.SH) stated on the investor interaction platform that shanghai haixin biotechnology co., ltd. does not involve AI medicine in its operation scope.

Gelonghui FinanceNov 22 04:13 ET

Earnings Are Growing at Shanghai Haixin Group (SHSE:600851) but Shareholders Still Don't Like Its Prospects

Simply Wall StNov 14 17:01 ET

Shanghai Haixin Group Co., Ltd. Third Quarter Report 2024

SZSIOct 29 12:00 ET · Announcements

Earnings Not Telling The Story For Shanghai Haixin Group Co., Ltd. (SHSE:600851) After Shares Rise 42%

Simply Wall StOct 8 18:26 ET

Shanghai Haixin Group's (SHSE:600851) Solid Earnings May Rest On Weak Foundations

Simply Wall StSep 1 20:36 ET